Stocks
Evolent Health (EVH) EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | 55.7 | 43.7 | -24.8 | 84.9 | -361.3 | 102.5 | ||
| Changes by years, y/y, % | -123% | -21% | -157% | -442% | -526% | +8.5% | |||
Evolent Health. EBITDA US GAAP, bln rub
Evolent Health. EBITDA US GAAP, changes, %
Evolent Health. EBITDA US GAAP, sum by quarters, bln rub
Evolent Health (EVH) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -28.7 | 15.3 | 23.3 | -366.8 | 13.6 | 102.5 | |
| Changes by years, y/y, % | -253% | -58% | +95% | -2 860% | -147% | |||
| Changes by quarters, q/q, % | -316% | -153% | +52% | -1 673% | -104% | |||
